Jan 20, 2021 (Baystreet.ca via COMTEX) -- At the moment, the global number of pandemic cases is up to 95.9 million, with 2.05 million unfortunate deaths. In the U.S., the number of cases is up to 24.2 million. In India, it’s up to 10.5 million. In Brazil, it’s 8.5 million. In Russia, it’s now up to 3.5 million.
Unfortunately, with the pandemic only expected to “get worse,” according to Dr. Anthony Fauci, there’s a greater need for testing.
Making matters worse, according to Reuters, demand for testing devices could outstrip supply for a long time, as noted by Roche Chief Executive Severin Schwan. Additionally, according to CNBC, labs nationwide appear to be struggling to get their hands on sufficient supply. The network further added that “the surge in demand is yet again stressing the supply chain.”
In New York City, publicly run testing sites are running short of rapid tests, which could pose a significant problem, as noted by the New York Daily News.
In short, there’s an urgent need for reliable testing
In fact, it and Fio Corporation - together Fionet Rapid Response Group – just announced the launch of its high-throughput COVID-19 rapid testing solution, using its Fionet technology, to administer on-site COVID-19 rapid testing and real-time tracking in high-volume settings like airports, sports & entertainment events, workplaces and schools.
Fionet’s high-throughput COVID-19 testing & tracking solution is a complete toolkit enabling rapid testing in high-volume settings using antigen-based rapid diagnostic tests (RDTs). The high-throughput toolkit acts as a “mobile testing lab”, enabling efficient onsite processing of RDTs, data capture and reporting in a variety of community-settings.
A single modular processing setup, with optimized workflows, requires two Fionet mobile testing devices, 2 personnel, and tabletop accessories to process up to 100 rapid antigen tests per hour. The flexibility of Fionet allows output to easily be scaled to handle over 1,000 tests per hour with additional devices and personnel, making it a solution for nearly any type of RDT testing program. In addition, the solution is designed to turn around test results in as little as 20 minutes, for minimal wait times and disruptions to travel journeys.
“We are extremely excited to launch our Fionet high-throughput rapid testing solution to help support the growing demand for rapid testing in high-volume settings like airports, workplaces and schools. Our solution is designed to be scalable and affordable, both of which are critical to enable a dramatic scale up COVID-19 testing & tracking.” said Dr Michael Greenberg, CEO of Fionet Rapid Response Group and CEO of Fio Corporation.
With this solution, FRR is well positioned to capitalize on the growing opportunity for rapid COVID-19 testing solutions in industries that have been crippled by restrictions due to the pandemic. There is growing pressure to ramp up rapid testing capacity at places like airports, cruise ships, arenas, workplaces, and schools. This has become increasingly important with multiple reports of a new, faster spreading COVID-19 variant making its ways around the world.